AIDX has released its 2025 Q4 earnings report, with revenue of 538.27K, reflecting a YoY change of 0.41%, and net profit of -1.31M, showing a YoY change of -4.70%. The Sankey diagram below clearly presents AIDX's revenue sources and cost distribution.

20/20 Biolabs (AIDX) key financial stats and ratios, covering profitability, financial health, and leverage.

20/20 Biolabs (AIDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

20/20 Biolabs (AIDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

20/20 Biolabs (AIDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Where does 20/20 Biolabs (AIDX) generate its revenue? Explore its key revenue streams and top earning regions.